0001493152-24-003756.txt : 20240125 0001493152-24-003756.hdr.sgml : 20240125 20240125163046 ACCESSION NUMBER: 0001493152-24-003756 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240119 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing FILED AS OF DATE: 20240125 DATE AS OF CHANGE: 20240125 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Biofrontera Inc. CENTRAL INDEX KEY: 0001858685 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 473765675 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40943 FILM NUMBER: 24562598 BUSINESS ADDRESS: STREET 1: 120 PRESIDENTIAL WAY, STREET 2: SUITE 330 CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: 781-245-1325 MAIL ADDRESS: STREET 1: 120 PRESIDENTIAL WAY, STREET 2: SUITE 330 CITY: WOBURN STATE: MA ZIP: 01801 8-K 1 form8-k.htm
false 0001858685 0001858685 2024-01-19 2024-01-19 0001858685 BFRI:CommonStockParValue0.001PerShareMember 2024-01-19 2024-01-19 0001858685 BFRI:PreferredStockPurchaseRightsMember 2024-01-19 2024-01-19 0001858685 BFRI:WarrantsToPurchaseCommonStockMember 2024-01-19 2024-01-19 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): January 19, 2024

 

Biofrontera Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   001-40943   47-3765675

(State or other jurisdiction

of incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

 

120 Presidential Way, Suite 330

Woburn, Massachusetts

   01801
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (781) 245-1325

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Exchange Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common stock, par value $0.001 per share   BFRI   The Nasdaq Stock Market LLC
         
Preferred Stock Purchase Rights       The Nasdaq Stock Market LLC
         
Warrants to purchase common stock   BFRIW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (the “Exchange Act”) (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 
 

 

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

 

Reference is made to the Current Report on Form 8-K filed by Biofrontera Inc. (the “Company”) with the Securities and Exchange Commission on November 29, 2023 regarding the notice received by the Company from The Nasdaq Stock Market (“Nasdaq”) on November 22, 2023 that the Company was no longer in compliance with certain of Nasdaq’s continued listing requirements. On January 8, 2024, the Company submitted to Nasdaq a plan to regain compliance with those requirements.

 

On January 19, 2024, Nasdaq notified the Company that, based on the Company’s compliance plan, Nasdaq has determined to grant the Company an extension of 180 calendar days from November 22, 2023 (i.e., by May 20, 2024) to regain compliance.

 

 
 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

January 25, 2024 Biofrontera Inc.
(Date) (Registrant)
   
  /s/ E. Fred Leffler III
  E. Fred Leffler, III
  Chief Financial Officer

 

 

 EX-101.SCH 2 bfri-20240119.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 3 bfri-20240119_def.xml XBRL DEFINITION FILE EX-101.LAB 4 bfri-20240119_lab.xml XBRL LABEL FILE Class of Stock [Axis] Common Stock Par Value 0. 001 Per Share [Member] Preferred Stock Purchase Rights [Member] Warrants To Purchase Common Stock [Member] Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Entity Information, Former Legal or Registered Name EX-101.PRE 5 bfri-20240119_pre.xml XBRL PRESENTATION FILE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.23.4
Cover
Jan. 19, 2024
Document Type 8-K
Amendment Flag false
Document Period End Date Jan. 19, 2024
Entity File Number 001-40943
Entity Registrant Name Biofrontera Inc.
Entity Central Index Key 0001858685
Entity Tax Identification Number 47-3765675
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 120 Presidential Way
Entity Address, Address Line Two Suite 330
Entity Address, City or Town Woburn
Entity Address, State or Province MA
Entity Address, Postal Zip Code 01801
City Area Code (781)
Local Phone Number 245-1325
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Entity Information, Former Legal or Registered Name Not Applicable
Common Stock Par Value 0. 001 Per Share [Member]  
Title of 12(b) Security Common stock, par value $0.001 per share
Trading Symbol BFRI
Security Exchange Name NASDAQ
Preferred Stock Purchase Rights [Member]  
Title of 12(b) Security Preferred Stock Purchase Rights
Security Exchange Name NASDAQ
Warrants To Purchase Common Stock [Member]  
Title of 12(b) Security Warrants to purchase common stock
Trading Symbol BFRIW
Security Exchange Name NASDAQ
XML 7 form8-k_htm.xml IDEA: XBRL DOCUMENT 0001858685 2024-01-19 2024-01-19 0001858685 BFRI:CommonStockParValue0.001PerShareMember 2024-01-19 2024-01-19 0001858685 BFRI:PreferredStockPurchaseRightsMember 2024-01-19 2024-01-19 0001858685 BFRI:WarrantsToPurchaseCommonStockMember 2024-01-19 2024-01-19 iso4217:USD shares iso4217:USD shares false 0001858685 8-K 2024-01-19 Biofrontera Inc. DE 001-40943 47-3765675 120 Presidential Way Suite 330 Woburn MA 01801 (781) 245-1325 Not Applicable false false false false Common stock, par value $0.001 per share BFRI NASDAQ Preferred Stock Purchase Rights NASDAQ Warrants to purchase common stock BFRIW NASDAQ true false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.4 html 4 25 1 false 3 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://biofrontera.com/role/Cover Cover Cover 1 false false All Reports Book All Reports bfri-20240119.xsd bfri-20240119_def.xml bfri-20240119_lab.xml bfri-20240119_pre.xml form8-k.htm http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form8-k.htm": { "nsprefix": "BFRI", "nsuri": "http://biofrontera.com/20240119", "dts": { "schema": { "local": [ "bfri-20240119.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "definitionLink": { "local": [ "bfri-20240119_def.xml" ] }, "labelLink": { "local": [ "bfri-20240119_lab.xml" ] }, "presentationLink": { "local": [ "bfri-20240119_pre.xml" ] }, "inline": { "local": [ "form8-k.htm" ] } }, "keyStandard": 25, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 0, "memberCustom": 3, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 4, "entityCount": 1, "segmentCount": 3, "elementCount": 67, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 30 }, "report": { "R1": { "role": "http://biofrontera.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-01-19", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-01-19", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true } } }, "tag": { "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "BFRI_PreferredStockPurchaseRightsMember": { "xbrltype": "domainItemType", "nsuri": "http://biofrontera.com/20240119", "localname": "PreferredStockPurchaseRightsMember", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Preferred Stock Purchase Rights [Member]" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] }, "BFRI_WarrantsToPurchaseCommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://biofrontera.com/20240119", "localname": "WarrantsToPurchaseCommonStockMember", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Warrants To Purchase Common Stock [Member]" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityInformationFormerLegalOrRegisteredName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInformationFormerLegalOrRegisteredName", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Information, Former Legal or Registered Name", "documentation": "Former Legal or Registered Name of an entity" } } }, "auth_ref": [] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]" } } }, "auth_ref": [] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Statement [Table]" } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://biofrontera.com/role/Cover" ], "auth_ref": [] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "BFRI_CommonStockParValue0.001PerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://biofrontera.com/20240119", "localname": "CommonStockParValue0.001PerShareMember", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Common Stock Par Value 0. 001 Per Share [Member]" } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://biofrontera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 15 0001493152-24-003756-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-24-003756-xbrl.zip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